Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2011

01-02-2011 | Original Article

Periodontal disease and type 2 diabetes: effects on salivary enzyme activities

Authors: Ebele J. Ikekpeazu, Emeka E. Neboh, Ignatius C. Maduka, Emeka G. Anyanwu, Nochie S. Okenyi

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2011

Login to get access

Abstract

There has been correlation between type 2 diabetes and periodontal disease and numerous markers in saliva, such as intracellular enzymes, which have been proposed as diagnostic tests for periodontal diseases. The present study estimates the activities of some salivary enzymes as possible means of diagnosis and treatment monitoring of periodontal disease patients with type 2 diabetes. A total of 320 subjects, of both sexes, aged 28–81 years were included in the study and divided into four groups of 80 subjects each. The groups were non-diabetics with periodontal disease, type 2 diabetics with periodontal disease, type 2 diabetics without periodontal disease and apparently healthy non-diabetics (controls). The activities of the enzymes, acid phosphatase (ACP), alkaline phosphatase (ALP), alanine transmainase (ALT), aspartate transaminase (AST), creatine kinase (CK) and lactate dehydrogenase (LDH) were determined in saliva of the subjects using standard spectrophotometric methods. For data analysis, paired students t-test was done using SPSS computer software and the results are presented as mean±SD. The enzyme activities (U/L) investigated showed significant differences (P < 0.001) in the enzymes studied in non-diabetics with periodontal disease and diabetics with periodontal disease, whereas only ALT was significant in diabetics without periodontal disease, compared with controls. A comparison of non-diabetics and the type 2 diabetics with periodontal disease showed significant increases in all the enzymes except ALP and CK in diabetics. Type 2 diabetes and periodontal disease leads to significant increases in salivary enzyme activities, with higher activity in co-occurrence. Salivary enzyme activities can be useful in diagnosis, treatment and management of the two conditions.
Literature
1.
go back to reference Ganong WF. Diabetes mellitus. In: Review of medical physiology, 21st edn. U.S.A, Mc Graw Hill Medical Publishing; 2003. p. 337–58. Ganong WF. Diabetes mellitus. In: Review of medical physiology, 21st edn. U.S.A, Mc Graw Hill Medical Publishing; 2003. p. 337–58.
2.
go back to reference Maduka IC, Neboh EE, Kwubiri UN. The prevalence of diabetic nephropathy in diabetic patients. Eur J Sci Res. 2009;26:255–9. Maduka IC, Neboh EE, Kwubiri UN. The prevalence of diabetic nephropathy in diabetic patients. Eur J Sci Res. 2009;26:255–9.
3.
go back to reference Harris SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med. 1999;341:1749–56.CrossRef Harris SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med. 1999;341:1749–56.CrossRef
4.
go back to reference Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.PubMedCrossRef Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.PubMedCrossRef
5.
go back to reference Ghosh S, Schork NJ. Genetic analysis of NIDDM. Diabetes. 1996;51:3353–61. Ghosh S, Schork NJ. Genetic analysis of NIDDM. Diabetes. 1996;51:3353–61.
6.
go back to reference Newman B, Selby JV, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 diabetes mellitus in male twins. Diabetologia. 1987;30:763–8.PubMedCrossRef Newman B, Selby JV, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 diabetes mellitus in male twins. Diabetologia. 1987;30:763–8.PubMedCrossRef
7.
go back to reference American Diabetes Asociation. Preventive foot care in diabetes (position statement). Diab Care. 2004;27:63–4.CrossRef American Diabetes Asociation. Preventive foot care in diabetes (position statement). Diab Care. 2004;27:63–4.CrossRef
8.
go back to reference Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontal. 2002;67:1094–102. Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontal. 2002;67:1094–102.
9.
go back to reference Shlossman M, Knowler WC, Pettit DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc. 1990;121:532–6.PubMed Shlossman M, Knowler WC, Pettit DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc. 1990;121:532–6.PubMed
10.
11.
go back to reference Patkak M. New weapons to combat an ancient disease. FASEB J. 2002;16:1853–64.CrossRef Patkak M. New weapons to combat an ancient disease. FASEB J. 2002;16:1853–64.CrossRef
12.
go back to reference Numabe Y, Hisano A, Kamoi K, Yoshie H, Ito K, Kurihara H. Analysis of saliva for periodontal diagnosis and monitoring. Periodontology. 2004;40:115–9. Numabe Y, Hisano A, Kamoi K, Yoshie H, Ito K, Kurihara H. Analysis of saliva for periodontal diagnosis and monitoring. Periodontology. 2004;40:115–9.
13.
go back to reference World Health Organization. Oral Health Survey Basic Methods, 3rd edn. Geneva: World Health Organization; 1987. p. 1–12. World Health Organization. Oral Health Survey Basic Methods, 3rd edn. Geneva: World Health Organization; 1987. p. 1–12.
14.
go back to reference Reitman S, Frankel S. Standard methods in Clinical Chemistry. Am J Clin Chem. 1957;28:56–9. Reitman S, Frankel S. Standard methods in Clinical Chemistry. Am J Clin Chem. 1957;28:56–9.
15.
go back to reference Cheesbrough M. Measurement of serum or plasma AST activity. In: Cheesebrough M, editor. District laboratory practice in tropical countries, Part 1. Low priced edition. United Kingdom: Cambridge University Press; 2005. p. 358–61.CrossRef Cheesbrough M. Measurement of serum or plasma AST activity. In: Cheesebrough M, editor. District laboratory practice in tropical countries, Part 1. Low priced edition. United Kingdom: Cambridge University Press; 2005. p. 358–61.CrossRef
16.
go back to reference Burtis C, Ashwood E, Border B. Liver functions. In: Aldrich JE, editor. Fundamentals of clinical chemistry. 5th ed. Saunders Company: Pennsylvania; 1996. p. 748–70. Burtis C, Ashwood E, Border B. Liver functions. In: Aldrich JE, editor. Fundamentals of clinical chemistry. 5th ed. Saunders Company: Pennsylvania; 1996. p. 748–70.
17.
go back to reference Ojo OP. Essential statistical calculation in biomedical analysis. In: A manual of calculations in clinical chemistry practicals: Ibadan, Nigeria, Timotunde Publishers; 1995. p. 91–113. Ojo OP. Essential statistical calculation in biomedical analysis. In: A manual of calculations in clinical chemistry practicals: Ibadan, Nigeria, Timotunde Publishers; 1995. p. 91–113.
18.
go back to reference Kaufman E, Lamstar IB. Analysis of saliva for periodontal diagnosis. J Clin Periodontol. 1998;27:453–65.CrossRef Kaufman E, Lamstar IB. Analysis of saliva for periodontal diagnosis. J Clin Periodontol. 1998;27:453–65.CrossRef
Metadata
Title
Periodontal disease and type 2 diabetes: effects on salivary enzyme activities
Authors
Ebele J. Ikekpeazu
Emeka E. Neboh
Ignatius C. Maduka
Emeka G. Anyanwu
Nochie S. Okenyi
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2011
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-010-0005-z

Other articles of this Issue 1/2011

International Journal of Diabetes in Developing Countries 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.